Molecular subtypes predict second breast events of ductal carcinoma in situ after breast-conserving surgery.
Yilan YangXu ZhaoXuanyi WangKairui JinJurui LuoZhaozhi YangXin MeiJinli MaZhimin ShaoZhen ZhangXingxing ChenXiao-Mao GuoXiaoli YuPublished in: Cancer medicine (2022)
The molecular subtype, especially the HER2 overexpression subtype, was the independent prognostic factor for DCIS patients who underwent BCS.